Microfoundations of Organizational Ambidexterity: An Analysis of the Design, Actors, and Decisions at a Multinational Biotech Firm

Balarezo, Jose; Nielsen, Bo Bernhard

doi:10.1109/tem.2020.2990184

Cited by 3 publications

(3 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Drawing on the concept of ambidexterity and the microfoundations approach, we develop an analytical framework of microfoundational ambidexterity to guide this study. It emphasizes the micro-level analytical focus of ambidexterity in MNCs (Balarezo & Nielsen, 2020;Christofi et al, 2021). More specifically, we delineate the conceptualization of ambidexterity into two types of knowledge sourcing activities at the micro level in light of the exploration and exploration dichotomy.…”

Section: An Analytical Frameworkmentioning

confidence: 99%

Ambidexterity in MNC knowledge sourcing in emerging economies: A microfoundational perspective

Dodourova

Zhao

Harzing

2023

International Business Review

View full text Add to dashboard Cite

Section: An Analytical Frameworkmentioning

confidence: 99%

Ambidexterity in MNC knowledge sourcing in emerging economies: A microfoundational perspective

Dodourova

Zhao

Harzing

2023

International Business Review

View full text Add to dashboard Cite

“…We argue that balanced ambidexterity, which involves a balance between exploration and exploitation, is central to the innovation performance of for‐profit organizations in the context of pandemics. For‐profit organizations in the health sector (e.g., pharmaceutical, biotechnology) engage in both exploration and exploitation to pursue incremental improvements to their existing offerings and radically new products (Balarezo & Nielsen, 2020; Winterhalter et al, 2016). The R&D unit of these companies, which mainly deals with radical innovations, is often spatially separated from other organizational units (Balarezo & Nielsen, 2020).…”

Section: Background Literature and Hypothesesmentioning

confidence: 99%

“…For‐profit organizations in the health sector (e.g., pharmaceutical, biotechnology) engage in both exploration and exploitation to pursue incremental improvements to their existing offerings and radically new products (Balarezo & Nielsen, 2020; Winterhalter et al, 2016). The R&D unit of these companies, which mainly deals with radical innovations, is often spatially separated from other organizational units (Balarezo & Nielsen, 2020). We expect that a spatial separation, given that an organization can give equal attention to exploration and exploitation, can have a positive impact on the organization's innovation performance in the context of pandemics.…”

Section: Background Literature and Hypothesesmentioning

confidence: 99%

Tackling pandemic‐related health grand challenges: The role of organizational ambidexterity, social equality, and innovation performance

Christofi

Stylianou

Hadjielias

et al. 2023

J of Product Innov Manag

View full text Add to dashboard Cite

The outbreak of COVID‐19 has brought the world to a standstill, with severe consequences on economic and health systems, requiring the identification and implementation of innovative solutions. This study's aims are threefold: first, to examine the impact of balanced and combined dimensions of ambidexterity on for‐profit organizations' innovation performance related to pandemics; second, to uncover whether and to what extent such innovation performance contributes to tackling global health grand challenges (i.e., mortality rate, risk of infection, and life expectancy) associated with pandemics; and, third, to investigate the moderating role of social equalities in health in the relationships between innovation performance and health‐related outcomes associated with pandemics. To uncover how for‐profit firms tackle the health‐related consequences of pandemics, we examine whether they have introduced product innovations to the health sector, defined as the market introduction of a new or significantly improved good, that have helped address the health challenges associated with the COVID‐19 pandemic. Using a panel dataset (1974–2020) with 15,062 firm‐year observations from the United States, we show that both the separate and the synchronous implementation of the balanced and combined dimensions of ambidexterity have a strong positive effect on firms' innovation performance and, particularly, innovation initiatives related to the pandemic. The results also reveal that innovation activities (i.e., granted patents and citations focused on COVID‐19) negatively affect mortality rate and risk of infection, as well as the positive impact of innovation on increasing life expectancy, with social equalities in health moderating this relationship. Taken together, we make novel contributions to the literature on how to tackle the health‐related consequences of pandemics through innovation and provide actionable managerial guidance on how firms can enhance innovation performance.

show abstract

Impacts of strategic exploitation and exploration on firms’ survival likelihood after crises: A decision-tree analysis

Chou

Liu

Yang

2023

Long Range Planning

View full text Add to dashboard Cite

Microfoundations of Organizational Ambidexterity: An Analysis of the Design, Actors, and Decisions at a Multinational Biotech Firm

Cited by 3 publications

References 53 publications

Ambidexterity in MNC knowledge sourcing in emerging economies: A microfoundational perspective

Ambidexterity in MNC knowledge sourcing in emerging economies: A microfoundational perspective

Tackling pandemic‐related health grand challenges: The role of organizational ambidexterity, social equality, and innovation performance

Impacts of strategic exploitation and exploration on firms’ survival likelihood after crises: A decision-tree analysis

Contact Info

Product

Resources

About